These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 29037523)

  • 1. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.
    Højgaard P; Klokker L; Orbai AM; Holmsted K; Bartels EM; Leung YY; Goel N; de Wit M; Gladman DD; Mease P; Dreyer L; Kristensen LE; FitzGerald O; Tillett W; Gossec L; Helliwell P; Strand V; Ogdie A; Terwee CB; Christensen R
    Semin Arthritis Rheum; 2018 Apr; 47(5):654-665. PubMed ID: 29037523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
    Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
    J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
    Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
    J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
    Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
    J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.
    Leung YY; Orbai AM; Ogdie A; Coates LC; de Wit M; Callis Duffin K; Eder L; Gladman DD; Goel N; Mease PJ; Strand V; FitzGerald O; Tillett W
    J Rheumatol Suppl; 2019 Jun; 95():33-37. PubMed ID: 31154402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
    Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
    J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.
    Duarte-García A; Leung YY; Coates LC; Beaton D; Christensen R; Craig ET; de Wit M; Eder L; Fallon L; FitzGerald O; Gladman DD; Goel N; Holland R; Lindsay C; Maxwell L; Mease P; Orbai AM; Shea B; Strand V; Veale DJ; Tillett W; Ogdie A
    J Rheumatol; 2019 Aug; 46(8):996-1005. PubMed ID: 30770518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement properties of patient reported outcome measures for spondyloarthritis: A systematic review.
    Png K; Kwan YH; Leung YY; Phang JK; Lau JQ; Lim KK; Chew EH; Low LL; Tan CS; Thumboo J; Fong W; Østbye T
    Semin Arthritis Rheum; 2018 Oct; 48(2):274-282. PubMed ID: 29573848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.
    Orbai AM; Mease PJ; de Wit M; Kalyoncu U; Campbell W; Tillett W; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; Gossec L; Lindsay CA; Steinkoenig I; Helliwell PS; McHugh NJ; Strand V; Ogdie A
    J Rheumatol; 2016 May; 43(5):965-9. PubMed ID: 27134271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
    Leung YY; Orbai AM; Tillett W; Ogdie A; Eder L; Goel N; Hojgaard P; Holland R; Mathew AJ; Lindsay CA; Antony A; Chau J; Christensen R; Coates LC; Mease PJ; Strand V; FitzGerald O; de Wit M; Duffin KC; Gladman DD
    J Rheumatol Suppl; 2021 Jun; 97():60-63. PubMed ID: 34074670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set.
    Elmamoun M; Leung YY; O'Sullivan D; Steinkoenig I; Chandran V; Gladman DD; FitzGerald OM; Orbai AM; Eder L
    J Rheumatol; 2019 Mar; 46(3):266-273. PubMed ID: 30385708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.
    Coates LC; FitzGerald O; Merola JF; Smolen J; van Mens LJJ; Bertheussen H; Boehncke WH; Callis Duffin K; Campbell W; de Wit M; Gladman D; Gottlieb A; James J; Kavanaugh A; Kristensen LE; Kvien TK; Luger T; McHugh N; Mease P; Nash P; Ogdie A; Rosen CF; Strand V; Tillett W; Veale DJ; Helliwell PS
    Arthritis Rheumatol; 2018 Mar; 70(3):345-355. PubMed ID: 29193765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional impairment measurement in psoriatic arthritis: Importance and challenges.
    Mease P; Strand V; Gladman D
    Semin Arthritis Rheum; 2018 Dec; 48(3):436-448. PubMed ID: 30029795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative.
    Antony A; Holland R; D'Agostino MA; Maksymowych WP; Bertheussen H; Schick L; Goel N; Ogdie A; Orbai AM; Højgaard P; Coates LC; Strand V; Gladman DD; Christensen R; Leung YY; Mease P; Tillett W
    Semin Arthritis Rheum; 2021 Apr; 51(2):367-386. PubMed ID: 33601193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
    Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
    J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review.
    Perez-Chada LM; Balak D; Cohen JM; Ogdie A; Merola JF; Gottlieb AB
    Expert Rev Clin Immunol; 2020 Mar; 16(3):267-283. PubMed ID: 32037912
    [No Abstract]   [Full Text] [Related]  

  • 19. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.
    Orbai AM; de Wit M; Mease P; Shea JA; Gossec L; Leung YY; Tillett W; Elmamoun M; Callis Duffin K; Campbell W; Christensen R; Coates L; Dures E; Eder L; FitzGerald O; Gladman D; Goel N; Grieb SD; Hewlett S; Hoejgaard P; Kalyoncu U; Lindsay C; McHugh N; Shea B; Steinkoenig I; Strand V; Ogdie A
    Ann Rheum Dis; 2017 Apr; 76(4):673-680. PubMed ID: 27613807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative.
    Perez-Chada LM; Salame NF; Ford AR; Duffin KC; Garg A; Gottlieb AB; Latella J; Merola JF; Armstrong AW
    Am J Clin Dermatol; 2020 Jun; 21(3):323-338. PubMed ID: 31950353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.